Mesoblast turns 10-bagger on FDA approval
The company has received US Food and Drug Administration approval for its drug Ryoncil, in a stunning turnaround from a year ago, when the same drug tanked the share price.
Victoria Business
Catholic hospitals blocked from private insurer boycott
Catholic Health Australia, whose members provide about a third of private hospital care nationally, will not be allowed to emulate Healthscope’s boycott of private health insurers.
The worrying warning sign behind Chalmers’ budget update
The commodity super-cycle is rapidly coming to an end, and Australia’s finances are nowhere near ready for this moment.
Insignia knocks back Bain approach
Insignia Financial has rejected Bain Capital’s $2.7bn takeover offer, described by its largest shareholder as “highly opportunistic”.
More Stories
Share tips: what our experts are recommending this week
International conflicts are causing concern in investment circles, and closer to home some ASX big guns are under pressure.
Has Qatar given Virgin’s Jayne Hrdlicka a second wind?
The Virgin boss is meant to be on the way out, but her landmark Qatar deal changes the equation with the airline’s private equity owners.
Green hydrogen hype fast runs out of steam
The glow of the superfuel is fading and this demands a rethink of its role in the Albanese government’s path to net zero.
CBA’s Comyn moves succession pieces around the board
There are two big messages coming out of the management reshuffle at the nation’s biggest bank.
Rio and BHP say the net zero tailwind is at their backs
The push to re-industrialise Western economies and the transition to net zero will provide strong tailwinds for the mining sector for decades to come, both Rio Tinto and BHP believe.
Resources rebound could spell more records for share market
Resources stocks have surged 17 per cent in a month but are still in negative territory for 2024. Experts examine the outlook.
Sigma offers concessions to get Chemist Warehouse deal done
The competition regulator’s decision on the $8.8bn merger of Sigma Healthcare and Chemist Warehouse has been pushed back to allow consultation on new Sigma undertakings.
This is our moment: Telstra CEO maps out her AI vision
Vicki Brady says big telcos have once again found themselves at the front of a tech revolution.
Resources rebound could spell more records for share market
Resources stocks have surged 17 per cent in a month but are still in negative territory for 2024. Experts examine the outlook.
Lincoln Minerals unveils huge magnetite resource
Lincoln Minerals has revealed it owns a one billion tonne-plus magnetite iron ore resource on the Eyre Peninsula, which was previously owned by a China-backed joint venture.
Original URL: https://www.themercury.com.au/business/victoria-business/page/26